Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer
Shidong Lv(University of Pittsburgh), Qiang Wei(Anhui Medical University)
Cited by 18
Related Papers
PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway
|BMC Cancer|2019|121
A2B adenosine receptor blockade inhibits growth of prostate cancer cells
|Purinergic Signalling|2013|95
Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer
|Journal of Clinical Investigation|2020|51
Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase–deficient renal cell carcinoma
|Genome Medicine|2023|30
Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer
|Translational Cancer Research|2022|6